Medical cannabis strains available in Poland: full list and how to read it

This page is a list of hemp flower strains available today in Polish pharmacies, not a ranking. The choice of strain is up to the attending physician, so the list indicates what exists at all and what cannot be inferred from this data. The compiled list for this service contains 141 sales positions, meaning 85 plant names from 16 manufacturers, and the number of names realistically available in one week is clearly lower, and no one publishes it in a form that could be verified. Below you will find a table, an explanation of why different sources provide different numbers, what cannot be inferred from the strain description, and answers to the most frequently asked questions about availability.

KEY INFORMATION
- The list compiled for this service: 141 sales positions, 85 plant names, 16 manufacturers.
- 64 out of 85 strains are carried by exactly one manufacturer, so one break in delivery removes the name from circulation.
- The declared content of active substances pertains to batches and has a tolerance of around 10 percent of the value.
- Hemp flower is issued only by a doctor’s prescription, in the Rpw category.

State of the list as of 05.09.2026. Presence in the list does not mean availability in your pharmacy.

How many strains of medical marijuana are available in Poland today?

There are currently eighty-five strains of hemp flower in Polish pharmacies, supplied by sixteen manufacturers in one hundred forty-one pharmacy positions. One strain may therefore be available in several versions at once, differing by manufacturer, declared content of active substances, and origin of the raw material.

This number is not fixed and should not be treated as a permanent state. Permits for market approval expire, deliveries are delayed, and new positions appear without notice. A strain present in the list one month can disappear the next, only to return six months later under a different manufacturer.

It is also worth distinguishing two things that merge into one in discussions about availability. The presence of a strain in the list means that someone is importing or producing it in Poland. It does not mean that your pharmacy carries it. The pharmacy orders what it orders and is not obliged to keep the entire assortment, so actual availability may be narrower than the list below. The reasons for this frequent change in numbers are explained in the sections about deliveries below.

Why do different sources give different numbers of strains?

Because each counts something different and rarely states exactly what. One source provides sales positions, another plant names, a third only manufacturer names, and a fourth estimates how many of these can realistically be ordered in one week. Four correct methods yield four different numbers.

A good example is the number that has opened this page until now. It spoke of a range from fifteen to twenty-five strains and attributed them to eight manufacturers named. We do not quote it here in full because four of those manufacturers are not on any list on which we base this service, and one of the names appears to be a misspelled name of an existing company. Repeating such a sentence, even with a disclaimer, would leave those names on the page and allow them to wander further.

Our own list gives different numbers: eighty-five cultivars in one hundred forty-one pharmacy positions from sixteen manufacturers. The discrepancy does not arise from the market, but from the counting method. That sentence did not provide either the measurement date or the unit, so it cannot be determined which market segment it described. A number without those two pieces of information ages faster than the text in which it stands, and the reader has no way to check whether it pertains to their pharmacy.

Hence the principle adopted in this service: with every number of strains, we state what has been counted and where the list comes from. Without this, two true numbers look like a contradiction, and the difference between them arises solely from the method, not the market.

Are you looking for this strain under a different name?

Four strains from the list function under two names at once. The medicinal product designation is the trade name of the responsible entity and does not have to correspond to the name of the breeding line under which the strain is known. If you are looking for one from the left column, the entry stands under the name on the right.

Which strains are available in Polish pharmacies today?

The list includes all strains along with the manufacturers who supply them, and the terpene described in sources as leading. The order is alphabetical, not ranking, and the strain name leads to its description.

• By leading terpene. Useful when the doctor indicated a profile, not a specific name.caryophyllene (30)myrcene (20)limonene (16)terpinolene (7)pinene (6)nerolidol (6)
• By manufacturer. Useful when ordering, as the pharmacy orders by manufacturer, not by strain name.S-LAB (38)Tilray (14)Canopy Growth (13)Synoptis Pharma (13)Aurora (10)Four 20 Pharma (6)Cosma (5)Cantourage (5)PhytoPur Bio (3)Suprobion (3)CanPoland (2)Bliss Pharma (2)Medalchemy (2)Medezin (1)ODI Pharma (1)Polfarmex (1)
• By availability. The more manufacturers, the greater the chance that the pharmacy will import something.10 strains from three or more manufacturers, 11 strains from two, 64 strains from one.
• By comparing two strains. Useful when the choice has narrowed down to two names and the difference is not visible from the description alone.Pink Kush and Gorilla GlueGorilla Glue and Beach CrasherGorilla Glue and Master KushGorilla Glue and Cataract KushBeach Crasher and Cataract KushCataract Kush and Galaxy Walker OGFrosted Cherry Cookies and Lilac DieselFrosted Cherry Cookies and PurpsGalaxy Walker OG and Lilac DieselGalaxy Walker OG and Master KushIsland Sweet Skunk and Lilac DieselLilac Diesel and PurpsBeach Crasher and Frosted Cherry CookiesIsland Sweet Skunk and Cataract KushPurps and Galaxy Walker OG
• By the question the patient comes with. Separate entries collect what has been shown in a given topic and what has not been shown. They are not an indication of the strain, as the selection is made by the attending physician.Cannabis and insomniaChronic pain and cannabisNeuropathic pain and cannabisAnxiety and medical marijuanaSpasticity in multiple sclerosisLack of appetiteStrains for the dayStrains for the night

Three quarters of the list are strains from one producer: 64 out of 85 names. What this means for availability is discussed in the section about the disappearance of strains from pharmacies.

Six names for the entire list mean that the leading terpene rarely narrows the selection below a dozen items, and with caryophyllene, there are thirty left. It does not replace the rest of the profile, and it is precisely in it that the sources diverge the most.

The portfolios of producers differ not only in size. The column with exclusive strains indicates how many items will disappear from pharmacies if that one entity halts supply.

Jump to letter: A B C D E F G H I J K L M N O P R S T U W Z

Why are there no THC percentages or price per gram in this table?

You will not find a list of strains with THC percentages or prices per gram here, and this is a decision, not an oversight. Both of these numbers appear to be the most useful information in the entire list, yet they are the least reliable for two completely different reasons.

The declared content of active substances actually includes a range, not a single value; the section on declared content below explains where this range comes from. Additionally, the same strain from four manufacturers has four different declarations. A single number in the table would suggest a precision that does not exist, which is why we provide the content as a range, and only in the description of a specific strain, where it can be explained where this range comes from.

The situation with prices is even simpler. The previous version of this page provided dozens of prices that could not be confirmed or kept up to date. Prices in pharmacies vary between establishments, change with the exchange rate and delivery, and permits expire faster than the table can be updated. A list with outdated prices is worse than a list without prices because it looks current. Ask the pharmacy that fills your prescription for the price, as they know their current offer.

What the strain list does not say about availability?

It does not say how much dried flower is in the warehouse, when the next delivery will come, or which pharmacy has a given item on the shelf today. It is a list of names currently in circulation, not a stock status. The permit for the admission of raw material can also be revoked and expires five years after issuance.

This last limit is often overlooked more than it deserves. The list of names appears to be a permanent document, but it is a snapshot of the legal state on the day it was collected. An item can fall off the list without any event on the pharmacy’s side, solely because the permit has expired or the manufacturer did not apply for its extension. Describing such a list as a list of what is available for purchase is misleading from the day of publication.

The second thing the list does not say is for formal reasons. Cannabis flower is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category, so which item is even eligible is determined by the content of the prescription, not the state of the list. A patient with a prescription for a specific raw material cannot simply take another name from the list, even if it is currently available. Therefore, this service maintains a list of names, and information about substitutes is left to the attending physician and pharmacist.

Why does a strain disappear from the pharmacy between one delivery and another?

Most often because it is carried by only one manufacturer. In the list, 64 out of 85 strains have exactly one company supplying them, so one break in delivery removes such a name from circulation entirely. For names carried by several companies, the disappearance of one of them is much less noticeable.

This distribution, shown above in the table and in the chart, is very uneven and is responsible for the impression that the assortment is jumping. With such a structure, a market crisis is not needed for an item to disappear for several weeks. One batch held for re-examination or one delay at the border is enough.

The second reason is simpler and less dramatic. A pharmacy with a permit orders raw material for specific prescriptions, not for stock, because dried flower in the Rpw category is associated with record-keeping and a limited shelf life. An item present in the warehouse does not have to be on the shelf in the pharmacy where the patient arrives with a prescription. Between one link and the other is an order that someone must place, and the time in which the wholesaler will fulfill it. This is enough for the same name to be available immediately in one city and only after a week in another.

What do imports and domestic production change in the continuity of supplies?

They change the length of the journey that a batch must take before it reaches the pharmacy. Dried flower imported from abroad goes through more links and more documents than dried flower released for circulation in the country, and each link is a place where delivery can be delayed. The list of strains does not show this, however.

The list records one company name for each item and does not determine at which stage of the chain that company stands. It can be a grower, it can package someone else’s raw material, or it can only release a batch for circulation. For this reason, we do not assign individual names to the country of cultivation nor do we numerically divide the market into imports and domestic production. That would be a guess based on the name’s sound, and such a guess can be wrong by an entire continent.

What this list shows indisputably is concentration. S-LAB alone carries 38 out of 85 strains, and 20 of them are not available from any other manufacturer. The portfolios of the other companies are summarized in the table above. A market built this way reacts to problems of one company as a whole, regardless of whether its dried flower came from abroad or is from domestic cultivation. Shortening the chain helps with timeliness, but it does not change the fact that for most names, alternatives simply do not exist. Who stands behind which strain, we detail in separate entries about manufacturers.

What does a change in the available strain mean for ongoing therapy?

That it is determined by the attending physician, not the list. A different item means a different manufacturer, a different batch, and a different examination of that batch, so even the same name of the plant does not guarantee the same raw material. Comparative studies on the effects of such a change are not in public circulation.

The lack of such studies is the answer here, not a gap in the text. No one has conducted a clinical trial in which patients were switched from one manufacturer’s item to another under the same trade name and measured what happens. It is known, however, that the declared content of active substances has an allowable tolerance, and the volatile profile can differ in subsequent batches, depending on cultivation and post-harvest processing. Two batches of the same name are therefore not the same material, even though the label looks identical.

Symptoms reported after cannabis flower are described for the entire group of raw materials, not for a single name. In these descriptions, dry mouth, daytime drowsiness, dizziness upon rapid standing, increased heart rate, and anxiety that intensifies with dosage are repeated. A symptom that appeared after switching to another item should be reported to the attending physician, not compared with descriptions circulating online. What the numbers on the packaging mean and how to read the profile of a single strain, we break down in a separate text, and the content of active substances is discussed there, where it is the topic.

What does the choice of strain start with if not the name?

The choice of medical marijuana strain rarely comes down to the brand. It is determined by the declared composition for a specific batch, the named symptom that is to subside, and the form in which the raw material will be administered. The trade name is a label for this set, not its cause, and does not tell what will be in the package issued at the pharmacy.

Cannabis flower is dispensed in Poland only by a doctor’s prescription, in the Rpw category. The prescription states the name of a specific preparation along with the quantity and method of use, and the pharmacy dispenses exactly what is written. Switching to another raw material requires a new document, not a conversation at the counter. Therefore, the choice of strain is practically a preparation for a conversation in the office, not a decision made in front of the shelf. The entire process from the visit to the prescription fulfillment is described in a separate text about the process of obtaining a prescription for medical marijuana.

This results in the order in which this text lays out the criteria. First, the symptom named as narrowly as possible, then the composition described in the batch documentation, then the method of administration, and only at the end the trade name, which summarizes all four with one word. The reverse path, from name to symptom, can lead to disappointment: the patient receives the raw material they requested and does not get an answer to the problem they came with.

This section is not a ranking, but a set of criteria. The assortment changes with the rhythm of deliveries and permits, so read the current state from the list above, which we refresh separately. The criteria themselves age more slowly than the list of names.

What cannot be read from the description of the strain?

Three things: what exactly will go into the package, how this batch differs from the previous one, and where the numbers next to the name come from. The description summarizes the breeding and commercial material, while the document describing a specific raw material remains the batch examination that the manufacturer performs for each batch before introducing it to circulation.

The same name from two manufacturers does not mean the same material. A plant grown in two facilities differs in growing conditions, harvest time, and drying method, and each of these things changes the composition of the finished raw material. The trade name is not a concept protected in a way that would enforce consistency of composition between manufacturers. It is a trademark of the breeding line, not a specification.

The division between these columns is practical, not academic. The description helps understand why two raw materials may be perceived differently, while the question of what you have in hand is determined solely by the documentation attached to the issued batch. This is what you ask the pharmacist about, not the article’s author. It is worth remembering this especially for new items in the list, whose description online was created before the first delivery to Polish pharmacies and may be a translation of the breeder’s material from another market.

What does the declared content of active substances mean?

It means the value applicable to the batch, not a constant feature of the strain. The declaration has a tolerance of up to ten percent of the value, so an item described as twenty percent actually falls between eighteen and twenty-two. A single number assigned to a name exaggerates precision by an order of magnitude and is often read as a measurement.

A higher content does not mean better raw material, only stronger, and that is not the same. The ratio between the two main active substances describes the chemotype and tells more about the material than the name: some items have an advantage of THC, others contain both substances alongside each other, and still others are based on cannabidiol. The dose and the rate of its increase are determined by the doctor on the prescription, and it is this record that applies, not the number printed on the packaging.

How to read the strain profile to avoid being misled?

The strain description usually consists of three layers that are easy to confuse: data from the manufacturer, user reports, and marketing material transcribed from breeding services. Only the first of these layers refers to a specific batch of raw material that can actually be purchased at the pharmacy upon presentation of a prescription.

The names of terpenes appearing in descriptions are often given along with percentage shares. We consciously do not repeat them, and the reason is measured, not stylistic. Three compilations of the same items summed the shares and came up with three different totals, none of which reach completeness. Since the sums do not close, each counts relative to something else, and none provides that something. A number without a denominator in a text about a drug looks like a measurement, but it is not.

Similarly with the lineage. It may be documented on the breeder’s side, and then we provide the source, but for twenty-five strains on this list, it has not been possible to establish it, and that is how it has been recorded. The lineage does not say what you will get at the pharmacy: that is determined by the batch and its examination. We break this down more broadly in the entry about reading the strain profile.

What does the strength of the strain depend on and is it worth following it?

Strength is often treated as the only criterion for selection, and this is the most common mistake when first encountering therapy. The declared content of active substances tells how much of them is in the raw material, but it does not say how much will reach the body or how it will act on a specific person.

The effect is primarily influenced by the method of administration, as the same strain gives two different courses with it.

The second component is the patient themselves: body mass, previous exposure, and the time of the last meal change the outcome more than a difference of a few percentage points between two items. Therefore, choosing a strain based on the highest declared value rarely leads to where the patient intended, and the parameters of administration are determined by the attending physician. We expand on this in a separate text about what determines strength and in the section about what the choice of strain starts with.

• Separately about the declaration from the label. Each entry shows how wide the range is behind a single number when considering tolerance.Dried flower 18 percentLabel of dried flower at twenty percentDried flower 22 percentDeclared 25 percent and power categories in scientific reviewsDeclared 27 percent and the harm sideThirty percent
• Separately about temperature. The vaporizer setting, the temperature of the dried flower, and boiling tables are three different quantities given in the same degrees.Vapor pressure, not boiling pointEleven terpenes, four states of dataVaporizer setting and temperature of the dried flower

How does a strain differ from a chemotype and does the division into indica and sativa mean anything?

Another source of misunderstanding are names that function like entire categories. The words Haze, Afghani, or OG Kush return with many breeders and many manufacturers, each time describing a different plant. Therefore, a common part of the name is not sufficient evidence of kinship: the parent must be indicated independently by two companies, with two different offspring. We break down taxonomy and chemotypes more broadly in the entry about strains and properties of cannabis.

Why does the method of administration weigh more than the name itself?

Because it determines when the effect appears and how long it lasts, and these two things are influenced much less by the strain. The onset and end times of action for both methods are summarized in the table above, in the section on strain strength. The delay after swallowing comes from the fact that the substance first passes through the digestive tract and the liver.

The table does not show the peak effect. With vaporization, it occurs after ten to thirty minutes, and after oral administration, it shifts to the second or third hour. This leads to the typical mistake of the first oral dose: the second dose taken out of impatience overlaps with the first.

A symptom that increases at night leads to a different form than a symptom that appears suddenly during the day, and it is worth bringing this distinction to the visit along with the description of the ailment. Vaporization requires equipment designed for pharmaceutical raw material and temperature settings, as it depends on which compounds will actually pass into the vapor. Smoking dried flower is not a method of administering medication because it does not allow for dose replication. The relationship between the device setting and the material in the chamber is broken down in a separate text about vaporizing dried flower.

Where to look for information about prescriptions, refunds, and transport across borders?

Not on this page, and this is a conscious decision. This page is a list of strains and that is what it deals with. The procedure for obtaining a prescription, teleconsultation, expiration date of the prescription, and rules for transporting raw material across borders have their own entry, maintained and updated completely separately from this list.

Separating these two topics benefits both. The strain list changes with deliveries and permits, while the rules for issuing prescriptions change with regulations, meaning at a completely different rhythm. Keeping them on one page would cause them to become outdated mutually: a correction to one topic would force a review of the other, and a reader looking for one thing would have to sift through the other. Separation also means that each of these texts answers a different question and can do so completely, instead of cutting off halfway to make room for the other topic.

So you will find everything about the procedure in the entry about how the process of obtaining a prescription for medical marijuana looks. Here remains one sentence that must be stated regardless of why you came: cannabis flower is a pharmaceutical raw material dispensed only by a doctor’s prescription in the Rpw category, and no item from the table above is available without a prescription.

Frequently Asked Questions

How many strains are available in Polish pharmacies?

Eighty-five strains in one hundred forty-one pharmacy items, from sixteen manufacturers. The number changes with deliveries and permits, so treat it as the state today, not as a permanent value.

Why do you not provide the price per gram?

Prices vary between pharmacies and change faster than the table can be updated. A list with outdated prices is worse than a list without prices because it looks current. Ask the pharmacy filling the prescription for the price.

Why does a strain disappear from the pharmacy between deliveries?

Most often because it is carried by only one manufacturer. This applies to 64 out of 85 names in the list, so one break in delivery removes such an item from circulation entirely.

Why are there no THC percentages here for the strains?

Because the declared value is subject to a tolerance of up to ten percent, and the same strain from four manufacturers has four different declarations. We provide the content as a range in the description of a specific strain.

Does the pharmacy have to carry all varieties from the list?

No. The pharmacy orders what it will, so actual availability may be narrower than the list. It is worth providing the manufacturer’s name when placing an order, rather than relying on selection based solely on the strain name.

What to do if the prescribed strain is not available at the pharmacy?

The matter is decided by the attending physician, and availability is confirmed by the pharmacy with a permit for the trade of narcotic substances. The list of names currently in circulation does not replace this conversation.

Where does the data on the leading terpene come from?

From a comparison of two independent sources describing profile compositions. They usually agree on the leading terpene, but diverge in the further part of the profile, and where they diverge, we state this directly.

Can these strains be purchased without a prescription?

No. Hemp flower is a pharmaceutical raw material issued only by a doctor’s prescription in the Rpw category. No item from the table above is available without a prescription.

The list is updated with each change in pharmacy items, and the status above is from 05.09.2026. Hemp flower is a pharmaceutical raw material in the Rpw category, issued only by a doctor’s prescription, and the choice of strain is determined by the attending physician. Editorial text: redakcja ubucha.pl. The material is for informational purposes and does not replace medical advice.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult your doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Published: 2026-05-11 · Updated: 2026-09-22